Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance.
Amodio V, Lamba S, Chilà R, Cattaneo CM, Mussolin B, Corti G, Rospo G, Berrino E, Tripodo C, Pisati F, Bartolini A, Aquilano MC, Marsoni S, Mauri G, Marchiò C, Abrignani S, Di Nicolantonio F, Germano G, Bardelli A. Amodio V, et al. Among authors: bardelli a. Cancer Cell. 2023 Jan 9;41(1):196-209.e5. doi: 10.1016/j.ccell.2022.12.003. Epub 2022 Dec 29. Cancer Cell. 2023. PMID: 36584674 Free PMC article.
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Mauri G, Patelli G, Gori V, Lauricella C, Mussolin B, Amatu A, Bencardino K, Tosi F, Bonazzina E, Bonoldi E, Bardelli A, Siena S, Sartore-Bianchi A. Mauri G, et al. Among authors: bardelli a. Front Oncol. 2022 Nov 7;12:1030232. doi: 10.3389/fonc.2022.1030232. eCollection 2022. Front Oncol. 2022. PMID: 36419886 Free PMC article.
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient.
Torchiaro E, Petti C, Arena S, Sassi F, Migliardi G, Mellano A, Porporato R, Basiricò M, Gammaitoni L, Berrino E, Montone M, Corti G, Crisafulli G, Marchiò C, Bardelli A, Medico E. Torchiaro E, et al. Among authors: bardelli a. Front Oncol. 2023 Feb 2;13:1130852. doi: 10.3389/fonc.2023.1130852. eCollection 2023. Front Oncol. 2023. PMID: 36816936 Free PMC article.
Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features.
Berrino E, Aquilano MC, Valtorta E, Amodio V, Germano G, Gusmini M, Gizzi K, Fenocchio E, Sapino A, Marsoni S, Sartore-Bianchi A, Bardelli A, Siena S, Bonoldi E, Marchiò C. Berrino E, et al. Among authors: bardelli a. Mod Pathol. 2023 Feb;36(2):100012. doi: 10.1016/j.modpat.2022.100012. Epub 2023 Jan 10. Mod Pathol. 2023. PMID: 36853785 Free article.
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Mauri G, Patelli G, Gori V, Lauricella C, Mussolin B, Amatu A, Bencardino K, Tosi F, Bonazzina E, Bonoldi E, Bardelli A, Siena S, Sartore-Bianchi A. Mauri G, et al. Among authors: bardelli a. Front Oncol. 2023 Mar 28;13:1147497. doi: 10.3389/fonc.2023.1147497. eCollection 2023. Front Oncol. 2023. PMID: 37056342 Free PMC article.
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity.
Bersani F, Picca F, Morena D, Righi L, Napoli F, Russo M, Oddo D, Rospo G, Negrino C, Castella B, Volante M, Listì A, Zambelli V, Benso F, Tabbò F, Bironzo P, Monteleone E, Poli V, Pietrantonio F, Di Nicolantonio F, Bardelli A, Ponzetto C, Novello S, Scagliotti GV, Taulli R. Bersani F, et al. Among authors: bardelli a. J Exp Clin Cancer Res. 2023 May 12;42(1):120. doi: 10.1186/s13046-023-02690-5. J Exp Clin Cancer Res. 2023. PMID: 37170152 Free PMC article.
Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells.
Sogari A, Rovera E, Grasso G, Mariella E, Reilly NM, Lamba S, Mauri G, Durinikova E, Vitiello PP, Lorenzato A, Avolio M, Piumatti E, Bonoldi E, Aquilano MC, Arena S, Sartore-Bianchi A, Siena S, Trusolino L, Donalisio M, Russo M, Di Nicolantonio F, Lembo D, Bardelli A. Sogari A, et al. Among authors: bardelli a. Cell Rep Med. 2024 Feb 20;5(2):101376. doi: 10.1016/j.xcrm.2023.101376. Epub 2024 Jan 15. Cell Rep Med. 2024. PMID: 38228147 Free PMC article.
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models.
Maione F, Oddo D, Galvagno F, Falcomatà C, Pandini M, Macagno M, Pessei V, Barault L, Gigliotti C, Mira A, Corti G, Lamba S, Riganti C, Castella B, Massaia M, Rad R, Saur D, Bardelli A, Di Nicolantonio F. Maione F, et al. Among authors: bardelli a. Mol Oncol. 2024 Feb 13. doi: 10.1002/1878-0261.13595. Online ahead of print. Mol Oncol. 2024. PMID: 38348572 Free article.
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers.
Mauri G, Patelli G, Roazzi L, Valtorta E, Amatu A, Marrapese G, Bonazzina E, Tosi F, Bencardino K, Ciarlo G, Mariella E, Marsoni S, Bardelli A, Bonoldi E, Sartore-Bianchi A, Siena S. Mauri G, et al. Among authors: bardelli a. J Clin Pathol. 2024 Feb 13:jcp-2023-209341. doi: 10.1136/jcp-2023-209341. Online ahead of print. J Clin Pathol. 2024. PMID: 38350716 Free article.
356 results